Practice Issues: Research Highlights - Nitroglycerin for osteoporosisA recent study provides data on the effects of nitrates on bone in postmenopausal women. A Life SaverHighlights of recent changes to CPR and first aid guidelines. Out with gout An update on managing acute attacks and using preventive therapies. Clinical Notes: Pediatric captopril formulations vary widely across Canada Variances makes it difficult to optimize captopril dosing in children, could lead to toxicity. Letters: Discussing Dabigatran I would like to comment on a few points discussed in the article on dabigatran (Medication Forum, April/May 2011). Drug News: June 2011 Byetta: second GLP-1 agonist for diabetes; Gilenya: first oral disease-modifying drug for MS; Nucynta CR: new opioid for moderate—moderate/severe pain. Pharmacists with anticoagulation expertise valued by docs Huge gains for clinical team in Northern Alberta. Practice Issues: The role of CETP inhibitors references What will be the likely role of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia? Clinical Notes: Drugs with adverse skeletal effects Certain drugs can adversely affect the skeleton and increase the risk of osteoporosis or fractures. Dalhousie student: 'My life is about to change' Part of a series of stories profiling graduating students. First Previous 400 401 402 403 404 Next Last
